✦ LIBER ✦

Effect of cylcoxygenase (COX)-2 specific inhibitor utilization on the incidence of gastrointestinal events in a managed care population

✍ Scribed by D.V Pettitt; G Singh; J.S Schwartz; J.L Goldstein

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Determinants of cycloxygenase (COX)-2 sp

✍ D.V Pettitt; G Singh; J.S Schwartz; J.L Goldstein 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 36 KB

The treatment with a COX-2 specific inhi

✍ Luigi Cobellis; Sandro Razzi; Simona De Simone; Annalisa Sartini; Antonio Fava; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 95 KB

PAR2: EFFECTS OF A PRIOR AUTHORIZATION P

✍ DM Hartung; DR Touchette; K Ketchum; DG Haxby 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

PCV23 THE EFFECT OF β-BLOCKER AND ACE IN

✍ J Abarca; DC Malone; EP Armstrong 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

The efficacy of rebamipide add-on therap

✍ Hasegawa, Masahiro; Horiki, Noriyuki; Tanaka, Kyosuke; Wakabayashi, Hiroki; Tano 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 303 KB

The effects of COX-2 specific inhibitors

✍ Joseph A. Puma; Alfonso E. Bello; Jennifer J. Rodriguez; John G. Fort 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 50 KB